Table 2.
Characteristic | N | High-risk, N = 4851 | Low-risk, N = 4851 | p-value2 |
---|---|---|---|---|
PRS-type | 966 | <0.001 | ||
Primary | 274 | 352 | ||
Recurrent | 185 | 126 | ||
Secondary | 23 | 6 | ||
Histology | 966 | <0.001 | ||
GBM | 312 | 62 | ||
LGG | 170 | 422 | ||
Grade | 966 | <0.001 | ||
WHO II | 42 | 228 | ||
WHO III | 128 | 194 | ||
WHO IV | 312 | 62 | ||
Gender | 970 | 0.3 | ||
Female | 191 | 208 | ||
Male | 294 | 277 | ||
Age | 969 | <0.001 | ||
≤41 | 180 | 260 | ||
>41 | 304 | 225 | ||
IDH mutation status | 921 | <0.001 | ||
Mutant | 132 | 368 | ||
Wild type | 340 | 81 | ||
1p/19q codeletion status | 896 | <0.001 | ||
Codeletion | 9 | 190 | ||
Non-codeletion | 433 | 264 | ||
MGMTp methylation status | 817 | 0.002 | ||
methylated | 210 | 246 | ||
un-methylated | 206 | 155 |
1Statistics presented: n.
2Statistical tests performed: chi-square test of independence.